Literature DB >> 19641669

Risk factors for coronary artery sclerosis in patients with diabetes.

Akihiro Nishiyama1, Chihiro Shikata, Nobuaki Kimura, Akio Imanishi, Noriyuki Hirai, Makoto Ohta, Nobuakira Takeda.   

Abstract

OBJECTIVE: To examine risk factors for coronary artery sclerosis in patients with diabetes mellitus.
METHODS: Patients with diabetes were divided into two groups based on whether their electrocardiogram (ECG) showed ischemic changes. In addition to traditional risk factors, other parameters (ie, serum levels of serotonin, homocysteine, thrombomodulin, plasminogen activator inhibitor-1, tissue plasminogen activator, vascular endothelial growth factor, intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1) were measured in both groups.
RESULTS: In the group with ischemic ECG changes (n=13), systolic blood pressure was significantly higher than in the group with no changes (n=18). There were no significant differences in the serum levels of other factors; however, body mass index, hemoglobin A1c, total cholesterol, low density lipoprotein cholesterol and triglyceride levels tended to be higher in the group with ischemic ECG changes.
CONCLUSIONS: Although the sample of patients was limited, these results suggest that strict control of traditional risk factors, especially high blood pressure, is important for preventing coronary artery sclerosis in patients with diabetes mellitus.

Entities:  

Keywords:  Coronary artery sclerosis; Diabetes mellitus; Hyperlipidemia; Hypertension; Risk factors

Year:  2005        PMID: 19641669      PMCID: PMC2716231     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  31 in total

1.  Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells.

Authors:  S Yamagishi; H Fujimori; H Yonekura; Y Yamamoto; H Yamamoto
Journal:  Diabetologia       Date:  1998-12       Impact factor: 10.122

2.  Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease.

Authors:  A D Blann; J Amiral; C N McCollum
Journal:  Eur J Haematol       Date:  1997-08       Impact factor: 2.997

3.  Tissue plasminogen activator, tissue plasminogen activator inhibitor and lipoprotein(a) in patients with coronary, epiaortic and peripheral occlusive artery disease.

Authors:  M Caputo; G Mantini; I Floriani; M Ciceri; A Noseda; L Bonomo
Journal:  Eur Heart J       Date:  1996-09       Impact factor: 29.983

4.  Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation.

Authors:  A Schultz; L Lavie; I Hochberg; R Beyar; T Stone; K Skorecki; P Lavie; A Roguin; A P Levy
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

5.  Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J Tuomilehto; D Rastenyte; W H Birkenhäger; L Thijs; R Antikainen; C J Bulpitt; A E Fletcher; F Forette; A Goldhaber; P Palatini; C Sarti; R Fagard
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

6.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

7.  Serotonin inhibits nitric oxide synthesis in rat vascular smooth muscle cells stimulated with interleukin-1.

Authors:  M Shimpo; U Ikeda; Y Maeda; K Kurosaki; K Okada; T Saito; K Shimada
Journal:  Eur J Pharmacol       Date:  1997-10-29       Impact factor: 4.432

8.  Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells.

Authors:  T Ito; U Ikeda; M Shimpo; K Yamamoto; K Shimada
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

9.  Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients.

Authors:  M Otsuki; K Hashimoto; Y Morimoto; T Kishimoto; S Kasayama
Journal:  Diabetes       Date:  1997-12       Impact factor: 9.461

10.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.